GYPA and atrial fibrillation: In addition to that, CD235a+ PS+ RBC-derived EVs may play a pro-coagulative role in AF patients, because in non-ST elevation myocardial infarction patients this biomarker predicted a higher risk of in-stent thrombosis after percutaneous coronary intervention [45].